How many institutions held RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in Q2 2023?

91 institutional investors reported RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) for Q2 2023. Use the holders table for investor-level position and value details.

RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

Q: What does CUSIP 75955J402 represent in this 13F holders report?

CUSIP 75955J402 is the security identifier for RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) used to aggregate holder disclosures.

CUSIP: 75955J402

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock ($.001 par value)
Shares outstanding: 74,702,121
Total 13F shares: 16,099,667
Share change: -1,684,664
Total reported value: $39,628,526
Put/Call ratio: 145%
Price per share: $2.46
Number of holders: 91
Value change: -$4,052,287
Number of buys: 40
Number of sells: 48

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 75955J402:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Deep Track Capital, LP	13F	Company	3.8%	2,837,818	$6,413,469	—	31 Mar 2023	13F
RTW INVESTMENTS, LP	13F	Company	2.9%	2,131,835	$4,817,947	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	2.5%	1,838,417	$4,154,822	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2%	1,504,979	$3,401,253	—	31 Mar 2023	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.6%	1,221,399	$2,755,000	—	31 Mar 2023	13F
PARSONS CAPITAL MANAGEMENT INC/RI	13F	Company	0.97%	722,166	$1,632,096	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.9%	670,033	$1,514,274	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.74%	551,096	$1,245,477	—	31 Mar 2023	13F
Palo Alto Investors LP	13F	Company	0.73%	542,100	$1,225,146	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.67%	502,343	$1,135,295	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.54%	404,275	$913,661	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.48%	357,600	$808,176	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.47%	347,874	$786,196	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.42%	313,175	$708,000	—	31 Mar 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.39%	288,946	$653,018	—	31 Mar 2023	13F
Walleye Capital LLC	13F	Company	0.35%	262,481	$593,207	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.35%	257,923	$582,906	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.34%	254,742	$575,717	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.28%	209,991	$474,579	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.27%	202,328	$457,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.27%	199,824	$451,602	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.24%	178,440	$404,000	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.21%	153,503	$346,917	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.15%	109,959	$248,507	—	31 Mar 2023	13F
AdvisorShares Investments LLC	13F	Company	0.14%	104,140	$235,356	—	31 Mar 2023	13F
Guild Investment Management, Inc.	13F	Company	0.14%	103,900	$234,814	—	31 Mar 2023	13F
FMR LLC	13F	Company	0.12%	89,478	$202,220	—	31 Mar 2023	13F
XTX Topco Ltd	13F	Company	0.12%	86,267	$194,963	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	78,114	$176,538	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.1%	77,379	$175,000	—	31 Mar 2023	13F
apricus wealth, LLC	13F	Company	0.1%	77,329	$174,764	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.1%	73,915	$167,048	—	31 Mar 2023	13F
PDT Partners, LLC	13F	Company	0.09%	69,362	$156,758	—	31 Mar 2023	13F
Ikarian Capital, LLC	13F	Company	0.09%	65,491	$148,010	—	31 Mar 2023	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.08%	62,598	$141,000	—	31 Mar 2023	13F
Spotlight Asset Group, Inc.	13F	Company	0.03%	20,000	$140,000	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.07%	55,568	$125,568	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.06%	43,962	$99,354	—	31 Mar 2023	13F
GROUP ONE TRADING LLC	13F	Company	0.06%	43,694	$98,748	—	31 Mar 2023	13F
OCCUDO QUANTITATIVE STRATEGIES LP	13F	Company	0.05%	39,160	$88,502	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.05%	37,635	$85,000	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.05%	37,501	$84,752	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.05%	37,334	$84,375	—	31 Mar 2023	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.05%	36,991	$83,600	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.05%	36,969	$83,550	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.04%	32,700	$73,902	—	31 Mar 2023	13F
MEYER HANDELMAN CO	13F	Company	0.04%	32,545	$73,552	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.04%	30,400	$68,704	—	31 Mar 2023	13F
TIEDEMANN ADVISORS, LLC	13F	Company	0.04%	30,215	$68,286	—	31 Mar 2023	13F
Pegasus Asset Management, Inc.	13F	Company	0.04%	26,958	$60,926	—	31 Mar 2023	13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2023

As of 30 Jun 2023, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,099,667 shares. The largest 10 holders included Deep Track Capital, LP, RTW INVESTMENTS, LP, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Palo Alto Investors LP, BlackRock Inc., CITADEL ADVISORS LLC, MILLENNIUM MANAGEMENT LLC, and Mirae Asset Global Investments Co., Ltd.. This page lists 92 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.